Within six months of starting a GLP-1 medication, households reduce grocery spending by an average of 5.3%.
A household doesn't take Ozempic, a person does. Are they implying that if everybody in the household takes Ozempic, as a group they see a 5% reduction? Or, any one person in the household causes a 5% reduction for the group? The average household in the US is 2.5 people...
So when one (or more) people in a household begins taking the drug, the household spending goes down by that much.
I'd go for this one. Which means the one person reduces their food intake by at least double the 5%.
Or possibly the other people in the household see them eating less and follow their example...
What I'd like to know is your last bit - is one quarter of a household eating 25% less on their own, or does "mom" on Ozempic cause "dad and 2 kids" to eat 5% less individually? The former isn't nearly as interesting to me as the latter...
See my parallel comment... are they reporting 1/4 of a household eats 25% individually (for a 5% reduction across a family of 4). Or, does one person eating 5% less cause the other 3 to also eat 5%... if it's the latter, this potentially has health impacts across people who aren't taking the drug.
If the primary shopper in the household is on GLP-1, I would expect the household expenditures to drop.